SCHEMBL21716348

SCHEMBL21716348

c1cc(-n2c3ccccc3c3c4ccccc4ccc32)c2cc3c4ccccc4n(-c4nc(-c5ccc6c(ccc7ccccc76)c5)nc5ccccc45)c3cc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.37
ROCK1 Q13464 1/20 0.37
PKN1 Q16512 1/20 0.37
PKN2 Q16513 1/20 0.37
CYP1A2 P05177 6/20 0.35
CYP3A4 P08684 6/20 0.35
CYP2D6 P10635 6/20 0.35
ALDH1A1 P00352 2/20 0.35
ALOX15 P16050 1/20 0.35
TP53 P04637 3/20 0.34
LMNA P02545 2/20 0.34
ABCG2 Q9UNQ0 4/20 0.33
TSHR P16473 4/20 0.33
USP2 O75604 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CYP2C19 P33261 1/20 0.33
PTGES O14684 1/20 0.33
ACP1 P24666 2/20 0.32
MAPK1 P28482 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717711 0.95 ROCK2 (0.39) ROCK2ROCK1PKN1PKN2CYP1A2
SCHEMBL21716570 0.93 ROCK2 (0.38) ROCK2ROCK1PKN1PKN2CYP1A2
SCHEMBL21717293 0.93 ABCG2 (0.36) ROCK2ROCK1PKN1PKN2CYP1A2
SCHEMBL21717260 0.90 ROCK2 (0.38) ROCK2ROCK1PKN1PKN2CYP1A2
SCHEMBL21716353 0.89 TDP1 (0.32) CYP1A2CYP3A4CYP2D6ABCG2TSHR
SCHEMBL21716461 0.86 GSR (0.36) ALDH1A1LMNAPTGESTDP1
SCHEMBL21213700 0.86 ROCK2 (0.38) ROCK2ROCK1PKN1PKN2CYP1A2
SCHEMBL21717467 0.86 ABCG2 (0.40) ROCK2ROCK1PKN1PKN2CYP1A2
SCHEMBL21213328 0.86 ROCK2 (0.43) ROCK2ROCK1PKN1PKN2CYP1A2
SCHEMBL21717275 0.86 MEN1 (0.34) ABCG2PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 ROCK2 3979/4885ROCK1 2759/4885PKN1 1535/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 ROCK2 3979/4885ROCK1 2759/4885PKN1 1535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.